| ￥3000 | |
| Z05357-100 | |
|
|
|
|
|
|
|
|
|
| Species | Human | ||||||
| Protein Construction |
|
||||||
| Purity | > 95% as determined by BisTris PAGE | ||||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||||
| Biological Activity | Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch. | ||||||
| Expression System | HEK293 | ||||||
| Theoretical Molecular Weight | 47.5 kDa | ||||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 50-70 kDa based on Bis-Tris PAGE result. | ||||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized GITR Ligand/TNFSF18 Trimer, His & Flag, Human, His Tag at 5 μg/ml(100μl/well) on the plate. Dose response curve for Human GITR, hFc Tag with the EC50 of 36.3ng/ml determined by ELISA. »
The purity of GITR Ligand/TNFSF18 Trimer, His & Flag, Human is greater than 95% as determined by SEC-HPLC. »
GITR Ligand/TNFSF18 Trimer, His & Flag, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | Glucocorticoid-induced TNFR-related protein (TNFRSF18, GITR, CD357), expressed by T cells, and its ligand (TNFSF18, GITRL), expressed by myeloid populations, provide co-stimulatory signals that boost T cell activity. Due to the important role that GITR plays in regulating immune functions, agonistic stimulation of GITR is a promising therapeutic concept. |
| Synonyms | TNFSF18; AITRL; TL6; GITRL; GITR Ligand |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
